Synthesis and activity of HIV protease inhibitors

被引:18
|
作者
Garrouste, P
Pawlowski, M
Tonnaire, T
Sicsic, S
Dumy, P
de Rosny, E
Reboud-Ravaux, M
Fulcrand, P
Martinez, J
机构
[1] Univ Montpellier 1, Fac Pharm, UMR 5810, F-34060 Montpellier 2, France
[2] Univ Montpellier 2, Fac Pharm, UMR 5810, F-34060 Montpellier, France
[3] Akad Med, Katedra Chemmii Farmaceut, PL-31065 Krakow, Poland
[4] Fac Pharm Chatenay Malabry, Biocis CNRS, URA 1843, F-92296 Chatenay Malabry, France
[5] Univ Lausanne, BCH Dorigny, Inst Organ Chem, CH-1015 Lausanne, Switzerland
[6] Univ Paris 07, Inst Jacques Monod, F-75251 Paris, France
关键词
HIV; protease; inhibitor; pseudopeptide; cyclic peptide;
D O I
10.1016/S0223-5234(98)80043-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report here the synthesis and activity of HIV protease inhibitors. Ln the first stage hydrophobic compounds incorporating a 'carba' bond surrogate or a beta-homologated residue were synthesized. Secondly, we synthesized cyclic compounds in which we incorporated 2-quinoline carboxylic acid in the P3 position and the amino-hydroxyindane moiety in the P'3. The last part of this work was dedicated to a structure/activity study of a peptide substrate. These modifications allowed us to work up the synthesis of new pseudopeptide bonds: amino-amide and hydroxy-amide, Compounds with activity in the micromolar range were actually a starting point for the synthesis of new protease inhibitors. (C) Elsevier, Paris.
引用
收藏
页码:423 / 436
页数:14
相关论文
共 50 条
  • [41] Synthesis of (+)-biotin derivatives as HIV-1 protease inhibitors
    Han, Q
    Lafontaine, J
    Bacheler, LT
    Rayner, MM
    Klabe, RM
    EricksonViitanen, S
    Lam, PYS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (12) : 1371 - 1374
  • [42] Design and synthesis of novel conformationally restricted HIV protease inhibitors
    Salituro, FG
    Baker, CT
    Court, JJ
    Deininger, DD
    Kim, EE
    Li, BQ
    Novak, FM
    Rao, BG
    Pazhanisamy, S
    Porter, MD
    Schairer, WC
    Tung, RD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3637 - 3642
  • [43] Synthesis and evaluation of imidazolidinones as nonpeptide HIV-protease inhibitors
    DeLucca, GV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 495 - 500
  • [44] PYRROLINONE-BASED HIV PROTEASE INHIBITORS - DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY - EVIDENCE FOR IMPROVED TRANSPORT
    SMITH, AB
    HIRSCHMANN, R
    PASTERNAK, A
    GUZMAN, MC
    YOKOYAMA, A
    SPRENGELER, PA
    DARKE, PL
    EMINI, EA
    SCHLEIF, WA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (45) : 11113 - 11123
  • [45] DESIGN, SYNTHESIS, AND ACTIVITY OF CONFORMATIONALLY-CONSTRAINED MACROCYCLIC PEPTIDE-BASED INHIBITORS OF HIV PROTEASE
    SMITH, RA
    COLES, PJ
    CHEN, JJ
    ROBINSON, VJ
    MACDONALD, ID
    CARRIERE, J
    KRANTZ, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (18) : 2217 - 2222
  • [46] Protease inhibitors for HIV infection
    Bartlett, JG
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (12) : 1086 - 1088
  • [47] Peptidomimetic inhibitors of HIV protease
    Randolph, JT
    DeGoey, DA
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (10) : 1079 - 1095
  • [48] HIV protease inhibitors and atherosclerosis
    Hui, DY
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03): : 317 - 318
  • [49] Bicyclic HIV protease inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (02) : 79 - 79
  • [50] Hiv-protease inhibitors
    不详
    AMERICAN JOURNAL OF NURSING, 2006, 106 (10) : 36 - 37